Document is current
Any future updates will be listed below
-
Authors
Averbuch, Dina https://orcid.org/0000-0001-9614-7274
de la Camara, Rafael https://orcid.org/0000-0002-8189-5779
Tridello, Gloria
Knelange, Nina Simone
Bykova, Tatiana A. https://orcid.org/0000-0002-4456-2369
Ifversen, Marianne https://orcid.org/0000-0002-2558-1935
Dobsinska, Veronika
Ayas, Mouhab https://orcid.org/0000-0002-5740-1302
Hamidieh, Amir Ali https://orcid.org/0000-0002-8935-079X
Pichler, Herbert https://orcid.org/0000-0001-5107-5123
Perez-Martinez, Antonio https://orcid.org/0000-0002-6436-9195
Cesaro, Simone https://orcid.org/0000-0002-8698-9547
Sundin, Mikael
Badell, Isabel
Bader, Peter https://orcid.org/0000-0003-4554-0265
Johansson, Jan-Erik
Mirci-Danicar, Oana
Sedlacek, Petr https://orcid.org/0000-0001-7895-2886
Paillard, Catherine
Gibson, Brenda
Lawson, Sarah
Kroeger, Nicolaus https://orcid.org/0000-0001-5103-9966
Corbacioglu, Selim
Mikulska, Malgorzata https://orcid.org/0000-0002-5535-4602
Piñana, Jose Luis https://orcid.org/0000-0001-8533-2562
Styczynski, Jan https://orcid.org/0000-0002-3158-119X
Ljungman, Per https://orcid.org/0000-0002-8281-3245
- License Information
-
More Information
Article History
Received: 22 July 2022
Revised: 9 February 2023
Accepted: 15 February 2023
First Online: 27 February 2023
Competing interests
: RC: advisor for AstraZeneca in EVUSHELD pre-exposure prophylaxis for SARS-CoV-2. The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Free to read: This content has been made available to all.
